Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson

Last Updated: January 23, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Sotrastaurin

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the drug development status for Sotrastaurin?

Sotrastaurin is an investigational drug.

There have been 6 clinical trials for Sotrastaurin. The most recent clinical trial was a Phase 2 trial, which was initiated on April 1st 2010.

The most common disease conditions in clinical trials are Uveal Neoplasms, Melanoma, and Leukemia, Lymphoid. The leading clinical trial sponsors are Novartis Pharmaceuticals, James Blachly, and Novartis.

Recent Clinical Trials for Sotrastaurin
Trial of AEB071 in Combination With BYL719 in Patients With MelanomaRichard D. CarvajalPhase 1
A Phase Ib/II Study of AEB071 and MEK162 in Adult Patients With Metastatic Uveal MelanomaArray BioPharmaPhase 1/Phase 2
Efficacy, Safety, Tolerability, Pharmacokinetics of Sotrastaurin-tacrolimus vs. Mycophenolic Acid-tacrolimus in de Novo Liver Transplant PatientsNovartis PharmaceuticalsPhase 2

See all Sotrastaurin clinical trials

Clinical Trial Summary for Sotrastaurin

Top disease conditions for Sotrastaurin
Top clinical trial sponsors for Sotrastaurin

See all Sotrastaurin clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.